Fig. 3From: LMP2-mRNA lipid nanoparticle sensitizes EBV-related tumors to anti-PD-1 therapy by reversing T cell exhaustionFlow cytometry results of the in vivo experiment. A CD8 + TCM% (CD8 + TEM%) of CD3 + T cells in spleens from the PBS and VAC group. B Typical flow cytometry graphs of A. C PD1 + CD8 + T % (TIGIT + CD8 + T %) of CD3 + T cells in tumors from the PBS, PD1, VAC, and VACPD1 groups. D, Typical flow cytometry graphs of CBack to article page